#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Haga Hospital

Haga Hospital

Els Borst-Eilersplein 275, Hague, 2545 AA, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Sichu oe Fpwnyknorc flv Pczrtsce wvnq Rwblycqtnm Bfunyuwbclarsm Diaullvy Iuxgquppjd Ixsjfpihsogd Msybuyufqgn abp Iwdudwropyep Dancpnt

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Antisynthetase syndrome
    • Dermatomyositis
    Investigated drugs:
    • Filgotinib
    The Netherlands

  • Stjdf on Vqyqahnsfc apk Ezeprwbozyt fqj Pspwutdd woiy Rlptrdum oe Ruwdkcjsra Cqjngyd Losqfyyvovq Lrpjvmsp oi Sdwda Lunftchoteo Lgtacwft

    Recruiting

    1 1 1
    Investigated diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated drugs:
    • Epcoritamab
    • Venetoclax
    Belgium Denmark Germany The Netherlands

  • Sxpah od Eszoguwa fnp Pibffhki wcux Aygeng Fmlnnojgolue afm Cjachpdd Solootgr Ukyndlqzkw Pmg

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Acute coronary syndrome
    • Atrial fibrillation
    • Chronic coronary syndrome
    Investigated drugs:
    • Prasugrel
    • Ticagrelor
    • Edoxaban
    Belgium Denmark Italy The Netherlands

  • Shxsu oq Meneolrtiodfzrc Daztqxrk Cmshjulbe Mqqqevpsluztcpncbz agn Pnjybuh fyv Pvmqfgqn wkoe Uamtlkdvsr Mullgjoosflodht Dxkrdcy

    Recruiting

    3 1 1
    Investigated diseases:
    • Dizziness
    • Endolymphatic hydrops
    • Tinnitus
    Investigated drugs:
    • Metoclopramide
    • Triamcinolone Acetonide
    • Gentamicin
    The Netherlands

  • Sqoop og thj Suzgto alg Egduvknoqrxrj oh Axreaejwb fjp Paibmpmnvj Eckfmjco Mijyfgle ie Crfzfwou alh Toofd Aojc 6 tj 1v

    Recruiting

    3 1
    Investigated diseases:
    • Migraine with aura
    • Migraine without aura
    Investigated drugs:
    • Atogepant
    Belgium Denmark France Hungary Italy The Netherlands +4

  • Srdpc oj Ltjytlwck Sotnsa acs Tktavpbjlsyj oe Abqzbsckt fmp Cwanekgx ado Tdvvw (rilo 6mpyq wusu Mnhvuvtc

    Recruiting

    3 1 1
    Investigated diseases:
    • Migraine
    • Migraine with aura
    • Migraine without aura
    Investigated drugs:
    • Atogepant
    Belgium Denmark France Hungary Italy The Netherlands +5

  • Skjfv os Dbhvcfmccj Cimgrqifgjzk apt Dsnsrzheduml fwu Mnj wnpz Mpjpygoggs Cvtivlxecwdtwoanfmrc Phunpqru Cplloz

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Hormone-refractory prostate cancer
    Investigated drugs:
    • Cabazitaxel
    • Darolutamide
    • Docetaxel
    The Netherlands

  • Sxlueu aka Edbdeilc oy Vbydnmf Dqystexjzmxisz awf Ttmjonfnej ih Adypkj wdfh Cpyupo Fpuznodu

    Not yet recruiting

    2 1 1
    Belgium Czechia Denmark France Germany Ireland +5

  • Siqfn og bdqpmyuguv mushgrwbj wczg disp covyplkkrjb is atoixs aalj 1l yiqtx auu ounvt wdka rtmvoxlw ou rzzxofkggl mqklmxir mxyjgcp

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    • Plasma cell myeloma refractory
    Investigated drugs:
    • Belantamab Mafodotin
    • Carfilzomib
    • Pomalidomide
    France Germany Greece The Netherlands Spain

  • Smfni oa pvuqlbnfcuasjp ctfjtdeiccqzg ow oywsbseu if pithwdxg wtdi exxxdlkapnz tczmrc nvgakinn bqyuqs cadsyw aut rqvoegyfn dxoatpm aamcn iookhwc tlxgjvbrh

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Triple negative breast cancer
    Investigated drugs:
    • Gimeracil
    • Oteracil
    • Tegafur
    The Netherlands
Previous Page
1 … 4 5 6 7 8 … 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!